Nuclear Medicine/Radiopharmaceutic Market Report

Global and Region Nuclear Medicine/Radiopharmaceutic Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：156
  • REPORT CODE：GMM959047
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nuclear Medicine/Radiopharmaceutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nuclear Medicine/Radiopharmaceuticmarket, defines the market attractiveness level of Nuclear Medicine/Radiopharmaceutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nuclear Medicine/Radiopharmaceutic industry, describes the types of Nuclear Medicine/Radiopharmaceutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nuclear Medicine/Radiopharmaceutic market and the development prospects and opportunities of Nuclear Medicine/Radiopharmaceutic industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nuclear Medicine/Radiopharmaceutic market in Chapter 13.

    By Player:

    • China Isotope Radiation

    • China

    • Bracco Imaging

    • Mallinckrodt

    • China

    • Dongcheng

    • Shanghai Atom Kexing

    • Cardinal Health

    • Jaco

    • Bayer Healthcare

    • China

    • China

    • Nordion

    • Europe

    • Europe

    • Eczacibasi-Monrol Nuclear Products

    • China

    • China

    • China

    • China

    • China

    • China

    • Lantheus Medical Imaging

    • Lantheus Medical Imaging

    • Lantheus Medical Imaging

    • Lantheus Medical Imaging

    By Type:

    • Diagnostic

    • Therapeutic

    By End-User:

    • Oncology

    • Thyroid

    • Cardiology

    • Others

    By Geography:

    • United States

    • Lantheus Medical Imaging

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nuclear Medicine/Radiopharmaceutic Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nuclear Medicine/Radiopharmaceutic Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nuclear Medicine/Radiopharmaceutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nuclear Medicine/Radiopharmaceutic Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nuclear Medicine/Radiopharmaceutic Market Analysis and Outlook to 2022

    • 7.1 Global Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)

    • 7.2 United States Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)

    • 7.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)

    • 7.4 China Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)

    • 7.5 Japan Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)

    • 7.6 India Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)

    • 7.7 South Korea Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)

    8 Region and Country-wise Nuclear Medicine/Radiopharmaceutic Market Analysis and Outlook to 2028

    • 8.1 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.2 United States Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.4 China Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.5 Japan Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.6 India Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.7 South Korea Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)

    9 Global Nuclear Medicine/Radiopharmaceutic Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diagnostic Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Thyroid Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Nuclear Medicine/Radiopharmaceutic Market Outlook by Types and Applications to 2028

    • 10.1 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Thyroid Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nuclear Medicine/Radiopharmaceutic Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nuclear Medicine/Radiopharmaceutic Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nuclear Medicine/Radiopharmaceutic Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nuclear Medicine/Radiopharmaceutic Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nuclear Medicine/Radiopharmaceutic Market Competitive Analysis

    • 14.1 China Isotope Radiation

      • 14.1.1 China Isotope Radiation Company Details

      • 14.1.2 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.2 China

      • 14.2.1 China Company Details

      • 14.2.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.3 Bracco Imaging

      • 14.3.1 Bracco Imaging Company Details

      • 14.3.2 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.4 Mallinckrodt

      • 14.4.1 Mallinckrodt Company Details

      • 14.4.2 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.5 China

      • 14.5.1 China Company Details

      • 14.5.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.6 Dongcheng

      • 14.6.1 Dongcheng Company Details

      • 14.6.2 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.7 Shanghai Atom Kexing

      • 14.7.1 Shanghai Atom Kexing Company Details

      • 14.7.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.8 Cardinal Health

      • 14.8.1 Cardinal Health Company Details

      • 14.8.2 Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.9 Jaco

      • 14.9.1 Jaco Company Details

      • 14.9.2 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Jaco Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.10 Bayer Healthcare

      • 14.10.1 Bayer Healthcare Company Details

      • 14.10.2 Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.11 China

      • 14.11.1 China Company Details

      • 14.11.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.12 China

      • 14.12.1 China Company Details

      • 14.12.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.13 Nordion

      • 14.13.1 Nordion Company Details

      • 14.13.2 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Nordion Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.14 Europe

      • 14.14.1 Europe Company Details

      • 14.14.2 Europe Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Europe Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.15 Europe

      • 14.15.1 Europe Company Details

      • 14.15.2 Europe Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Europe Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.16 Eczacibasi-Monrol Nuclear Products

      • 14.16.1 Eczacibasi-Monrol Nuclear Products Company Details

      • 14.16.2 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.17 China

      • 14.17.1 China Company Details

      • 14.17.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.18 China

      • 14.18.1 China Company Details

      • 14.18.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.19 China

      • 14.19.1 China Company Details

      • 14.19.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.20 China

      • 14.20.1 China Company Details

      • 14.20.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.21 China

      • 14.21.1 China Company Details

      • 14.21.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.22 China

      • 14.22.1 China Company Details

      • 14.22.2 China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 China Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.23 Lantheus Medical Imaging

      • 14.23.1 Lantheus Medical Imaging Company Details

      • 14.23.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.24 Lantheus Medical Imaging

      • 14.24.1 Lantheus Medical Imaging Company Details

      • 14.24.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.25 Lantheus Medical Imaging

      • 14.25.1 Lantheus Medical Imaging Company Details

      • 14.25.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • 14.26 Lantheus Medical Imaging

      • 14.26.1 Lantheus Medical Imaging Company Details

      • 14.26.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nuclear Medicine/Radiopharmaceutic

    • Figure Nuclear Medicine/Radiopharmaceutic Picture

    • Table Global Nuclear Medicine/Radiopharmaceutic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine/Radiopharmaceutic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine/Radiopharmaceutic Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)

    • Figure United States Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure China Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Thyroid Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Thyroid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nuclear Medicine/Radiopharmaceutic Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nuclear Medicine/Radiopharmaceutic Export by Region (Top 5 Countries) (2017-2028)

    • Table China Isotope Radiation (Foundation Year, Company Profile and etc.)

    • Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Bracco Imaging (Foundation Year, Company Profile and etc.)

    • Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Mallinckrodt (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Dongcheng (Foundation Year, Company Profile and etc.)

    • Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongcheng Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Shanghai Atom Kexing (Foundation Year, Company Profile and etc.)

    • Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Cardinal Health (Foundation Year, Company Profile and etc.)

    • Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Jaco (Foundation Year, Company Profile and etc.)

    • Table Jaco Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jaco Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Bayer Healthcare (Foundation Year, Company Profile and etc.)

    • Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Nordion (Foundation Year, Company Profile and etc.)

    • Table Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Europe (Foundation Year, Company Profile and etc.)

    • Table Europe Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Europe Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Europe (Foundation Year, Company Profile and etc.)

    • Table Europe Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Europe Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Eczacibasi-Monrol Nuclear Products (Foundation Year, Company Profile and etc.)

    • Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table China (Foundation Year, Company Profile and etc.)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Lantheus Medical Imaging (Foundation Year, Company Profile and etc.)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Lantheus Medical Imaging (Foundation Year, Company Profile and etc.)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Lantheus Medical Imaging (Foundation Year, Company Profile and etc.)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service

    • Table Lantheus Medical Imaging (Foundation Year, Company Profile and etc.)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US